Gilead Sciences Stock (NASDAQ: GILD) stock price, news, charts, stock research, profile.
Open | $65.500 |
Close | - |
Volume / Avg. | 1.567M / 7.336M |
Day Range | 65.050 - 66.351 |
52 Wk Range | 65.090 - 87.865 |
Market Cap | $81.901B |
P/E Ratio | 14.504 |
Dividend Yield | 4.720% |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | 1.81% |
Days to Cover | 3.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gilead Sciences (NASDAQ: GILD) through any online brokerage.
Other companies in Gilead Sciences’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Gilead Sciences (NASDAQ: GILD) was reported by Needham on Friday, April 26, 2024. The analyst firm set a price target for 0.00 expecting GILD to fall to within 12 months (a possible -100.00% downside). 32 analyst firms have reported ratings in the last year.
The stock price for Gilead Sciences (NASDAQ: GILD) is $65.68 last updated Today at April 26, 2024 at 9:45 AM EDT.
A quarterly cash dividend of $0.77 per share of Class A Common Stock. The quarterly cash dividend was payable on March 28, 2024 to stockholders of record on March 14, 2024.
Gilead Sciences’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Gilead Sciences.
Gilead Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.